[Skip to content]

EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - Awareness EPDA - Coping Strategies EPDA - Medical Information EPDA - Patient Guide EPDA - Site Map EPDA - Rewrite Tomorrow
EUROPEAN PARKINSON'S DISEASE ASSOCIATION
.

Paradoxical worsening of gait with levodopa in Parkinson disease

Paradoxical worsening of gait with levodopa in Parkinson disease
xxx
Neurology

14 February 2012
Chen R


Despite many recent advances in the treatment of Parkinson disease (PD), levodopa is still the most effective medication for PD. While there are many "nondopaminergic" features of PD that do not improve with levodopa, PD motor symptoms generally improve with dopaminergic medications.

However, not all the motor manifestations of PD are improved to the same extent and some may not respond at all to levodopa. Tremor is often less responsive to levodopa than bradykinesia. Different aspects of bradykinesia may even respond differently. For example, recent studies showed that with self-paced finger and hand movement tasks similar to those used in the Unified Parkinson's Disease Rating Scale, levodopa improved the speed of movement but had little effect on the amplitude of movement and on movement fatigue, although impairment of movement amplitude was more prevalent than impairment of speed in PD.

In contrast, when finger tapping was paced to an external rhythm, patients with PD had a dramatic reduction in the amplitude of movement when the tapping rate was higher than 2 Hz and this reduction in amplitude did not improve with levodopa.